Market Place
Upload your Marketing & Sales content on your company Virtual Booth, click HERE
X
Active Filter(s):
Details:
Sarfez’s FDA-approved, once-a-day novel formulation of loop diuretic torsemide, SOAANZ®, provides a new treatment option for patients suffering from heart failure who experience persistent edema or swelling in the lower limbs and/or abdomen.
Lead Product(s): Torsemide
Therapeutic Area: Cardiology/Vascular Diseases Product Name: Soaanz
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Novo Integrated Sciences
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement November 30, 2022
